Latest round: IPO. Rodney Varner co-founded Genprex in 2009, a clinical-stage gene therapy company focused on developing therapies for cancer and diabetes.
Rodney Varner co-founded Genprex in 2009, a clinical-stage gene therapy company focused on developing therapies for cancer and diabetes. He served as President and CEO since 2016 and on its board of directors since 2012. Under his leadership, Genprex became a publicly traded company in 2018.
Full founder directory · Investor directory · Company funding database · Fundraising library